Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPINIROLE vs ROZANOLIXIZUMAB-NOLI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPINIROLE vs ROZANOLIXIZUMAB-NOLI: Safety Overview

Metric ROPINIROLE ROZANOLIXIZUMAB-NOLI
Total FAERS Reports 4,239 349
Deaths Reported 310 4
Death Rate 7.3% 1.1%
Hospitalizations 1,192 84
Average Patient Age 65.5 yrs 55.1 yrs
% Female Patients 56.7% 63.3%
FDA Approval Date Apr 10, 2009 N/A
Manufacturer SOLCO HEALTHCARE US, LLC N/A
Route ORAL N/A
Marketing Status Discontinued Prescription